Duchesnay Inc.

A former US Federal Trade Commission official offered simple advice for biopharma companies retaining celebrity influencers to promote products on social media. “Do your research, require a written co

The increased risks of using a celebrity for drug promotion emerged in a new US Food and Drug Administration advertising and promotion untitled letter for AbbVie Inc. ’s migraine drug Ubrelvy. Cele

A US Food and Drug Administration advertising and promotion untitled letter for Kaleo’s Auvi-Q (epinephrine injection) highlights the enforcement risks companies shoulder when turning to a celebrity i

The US Food and Drug Administration’s seven-year delay in updating guidance on social media promotion of prescription drugs has garnered the attention of two Senators, who want new guidance by the end